Compare ABCL & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABCL | PGY |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | Canada | United States |
| Employees | N/A | 518 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 971.3M |
| IPO Year | 2020 | N/A |
| Metric | ABCL | PGY |
|---|---|---|
| Price | $4.21 | $13.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $8.40 | ★ $34.50 |
| AVG Volume (30 Days) | ★ 4.0M | 2.9M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $75,128,000.00 | N/A |
| Revenue This Year | N/A | $14.27 |
| Revenue Next Year | $21.85 | $14.39 |
| P/E Ratio | ★ N/A | $13.54 |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $1.94 | $10.40 |
| 52 Week High | $6.52 | $44.99 |
| Indicator | ABCL | PGY |
|---|---|---|
| Relative Strength Index (RSI) | 70.31 | 51.93 |
| Support Level | $3.91 | $10.78 |
| Resistance Level | $4.76 | $15.57 |
| Average True Range (ATR) | 0.21 | 0.73 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 83.66 | 46.76 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.